According to Edwards Lifesciences's latest financial reports the company's current EPS (TTM) is 1,95ย โฌ. In 2024 the company made an earnings per share (EPS) of 5,86ย โฌ an increase over its 2023 EPS that were of 1,94ย โฌ.